CONJUGATED SUBSTANCE OF SUBSTITUTED HYDROXYPYRIDINE COMPOUND
PROBLEM TO BE SOLVED: To provide a conjugated substance of a new substituted hydroxypyridine compound having a type IV phosphodiesterase inhibitory activity, or its physiologically acceptable salts. SOLUTION: This medicine of the type IV phosphodiesterase inhibitory agent contains the conjugated sub...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KONDO KAORI MISE MASAFUMI TERANISHI YASUHIRO NAKAMURA TOSHIYA NISHIMURA NAOHIRO MIZUKI YASUYUKI ITOU MARI MATSUMOTO SATOSHI NIKO TOMOHIRO TODA HIROSHI |
| description | PROBLEM TO BE SOLVED: To provide a conjugated substance of a new substituted hydroxypyridine compound having a type IV phosphodiesterase inhibitory activity, or its physiologically acceptable salts. SOLUTION: This medicine of the type IV phosphodiesterase inhibitory agent contains the conjugated substance of a compound expressed by formula (I) or its physiologically acceptable salts as an active ingredient. The incorporated substance is a special conjugated substance having a pharmacological activity by itself and characterized by existing in a target tissue of its efficacy in a certain amount, also being distributed in a tissue associated with its adverse effect in an extremely small amount, supplying the unchanged substance continuously by being dissociated in the target tissue and having a high solubility. COPYRIGHT: (C)2006,JPO&NCIPI |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2006021996A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2006021996A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2006021996A3</originalsourceid><addsrcrecordid>eNrjZLBx9vfzCnV3DHF1UQgOdQoOcfRzdlXwd4NwPENCQRIekS5B_hGRAZFBni6efq4Kzv6-Af6hfi48DKxpiTnFqbxQmptByc01xNlDN7UgPz61uCAxOTUvtSTeK8DIwMDMwMjQ0tLM0ZgoRQCpdCq-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CONJUGATED SUBSTANCE OF SUBSTITUTED HYDROXYPYRIDINE COMPOUND</title><source>esp@cenet</source><creator>KONDO KAORI ; MISE MASAFUMI ; TERANISHI YASUHIRO ; NAKAMURA TOSHIYA ; NISHIMURA NAOHIRO ; MIZUKI YASUYUKI ; ITOU MARI ; MATSUMOTO SATOSHI ; NIKO TOMOHIRO ; TODA HIROSHI</creator><creatorcontrib>KONDO KAORI ; MISE MASAFUMI ; TERANISHI YASUHIRO ; NAKAMURA TOSHIYA ; NISHIMURA NAOHIRO ; MIZUKI YASUYUKI ; ITOU MARI ; MATSUMOTO SATOSHI ; NIKO TOMOHIRO ; TODA HIROSHI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a conjugated substance of a new substituted hydroxypyridine compound having a type IV phosphodiesterase inhibitory activity, or its physiologically acceptable salts. SOLUTION: This medicine of the type IV phosphodiesterase inhibitory agent contains the conjugated substance of a compound expressed by formula (I) or its physiologically acceptable salts as an active ingredient. The incorporated substance is a special conjugated substance having a pharmacological activity by itself and characterized by existing in a target tissue of its efficacy in a certain amount, also being distributed in a tissue associated with its adverse effect in an extremely small amount, supplying the unchanged substance continuously by being dissociated in the target tissue and having a high solubility. COPYRIGHT: (C)2006,JPO&NCIPI</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060126&DB=EPODOC&CC=JP&NR=2006021996A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060126&DB=EPODOC&CC=JP&NR=2006021996A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KONDO KAORI</creatorcontrib><creatorcontrib>MISE MASAFUMI</creatorcontrib><creatorcontrib>TERANISHI YASUHIRO</creatorcontrib><creatorcontrib>NAKAMURA TOSHIYA</creatorcontrib><creatorcontrib>NISHIMURA NAOHIRO</creatorcontrib><creatorcontrib>MIZUKI YASUYUKI</creatorcontrib><creatorcontrib>ITOU MARI</creatorcontrib><creatorcontrib>MATSUMOTO SATOSHI</creatorcontrib><creatorcontrib>NIKO TOMOHIRO</creatorcontrib><creatorcontrib>TODA HIROSHI</creatorcontrib><title>CONJUGATED SUBSTANCE OF SUBSTITUTED HYDROXYPYRIDINE COMPOUND</title><description>PROBLEM TO BE SOLVED: To provide a conjugated substance of a new substituted hydroxypyridine compound having a type IV phosphodiesterase inhibitory activity, or its physiologically acceptable salts. SOLUTION: This medicine of the type IV phosphodiesterase inhibitory agent contains the conjugated substance of a compound expressed by formula (I) or its physiologically acceptable salts as an active ingredient. The incorporated substance is a special conjugated substance having a pharmacological activity by itself and characterized by existing in a target tissue of its efficacy in a certain amount, also being distributed in a tissue associated with its adverse effect in an extremely small amount, supplying the unchanged substance continuously by being dissociated in the target tissue and having a high solubility. COPYRIGHT: (C)2006,JPO&NCIPI</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBx9vfzCnV3DHF1UQgOdQoOcfRzdlXwd4NwPENCQRIekS5B_hGRAZFBni6efq4Kzv6-Af6hfi48DKxpiTnFqbxQmptByc01xNlDN7UgPz61uCAxOTUvtSTeK8DIwMDMwMjQ0tLM0ZgoRQCpdCq-</recordid><startdate>20060126</startdate><enddate>20060126</enddate><creator>KONDO KAORI</creator><creator>MISE MASAFUMI</creator><creator>TERANISHI YASUHIRO</creator><creator>NAKAMURA TOSHIYA</creator><creator>NISHIMURA NAOHIRO</creator><creator>MIZUKI YASUYUKI</creator><creator>ITOU MARI</creator><creator>MATSUMOTO SATOSHI</creator><creator>NIKO TOMOHIRO</creator><creator>TODA HIROSHI</creator><scope>EVB</scope></search><sort><creationdate>20060126</creationdate><title>CONJUGATED SUBSTANCE OF SUBSTITUTED HYDROXYPYRIDINE COMPOUND</title><author>KONDO KAORI ; MISE MASAFUMI ; TERANISHI YASUHIRO ; NAKAMURA TOSHIYA ; NISHIMURA NAOHIRO ; MIZUKI YASUYUKI ; ITOU MARI ; MATSUMOTO SATOSHI ; NIKO TOMOHIRO ; TODA HIROSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2006021996A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>KONDO KAORI</creatorcontrib><creatorcontrib>MISE MASAFUMI</creatorcontrib><creatorcontrib>TERANISHI YASUHIRO</creatorcontrib><creatorcontrib>NAKAMURA TOSHIYA</creatorcontrib><creatorcontrib>NISHIMURA NAOHIRO</creatorcontrib><creatorcontrib>MIZUKI YASUYUKI</creatorcontrib><creatorcontrib>ITOU MARI</creatorcontrib><creatorcontrib>MATSUMOTO SATOSHI</creatorcontrib><creatorcontrib>NIKO TOMOHIRO</creatorcontrib><creatorcontrib>TODA HIROSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KONDO KAORI</au><au>MISE MASAFUMI</au><au>TERANISHI YASUHIRO</au><au>NAKAMURA TOSHIYA</au><au>NISHIMURA NAOHIRO</au><au>MIZUKI YASUYUKI</au><au>ITOU MARI</au><au>MATSUMOTO SATOSHI</au><au>NIKO TOMOHIRO</au><au>TODA HIROSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CONJUGATED SUBSTANCE OF SUBSTITUTED HYDROXYPYRIDINE COMPOUND</title><date>2006-01-26</date><risdate>2006</risdate><abstract>PROBLEM TO BE SOLVED: To provide a conjugated substance of a new substituted hydroxypyridine compound having a type IV phosphodiesterase inhibitory activity, or its physiologically acceptable salts. SOLUTION: This medicine of the type IV phosphodiesterase inhibitory agent contains the conjugated substance of a compound expressed by formula (I) or its physiologically acceptable salts as an active ingredient. The incorporated substance is a special conjugated substance having a pharmacological activity by itself and characterized by existing in a target tissue of its efficacy in a certain amount, also being distributed in a tissue associated with its adverse effect in an extremely small amount, supplying the unchanged substance continuously by being dissociated in the target tissue and having a high solubility. COPYRIGHT: (C)2006,JPO&NCIPI</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2006021996A |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | CONJUGATED SUBSTANCE OF SUBSTITUTED HYDROXYPYRIDINE COMPOUND |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T22%3A58%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KONDO%20KAORI&rft.date=2006-01-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2006021996A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |